The Library
Identification of a novel β-replacement reaction in the biosynthesis of 2,3-diaminobutyric acid in peptidylnucleoside mureidomycin A
Tools
Lam, Wai-Ho, Rychli, Kathrin and Bugg, Tim. (2008) Identification of a novel β-replacement reaction in the biosynthesis of 2,3-diaminobutyric acid in peptidylnucleoside mureidomycin A. Organic & Biomolecular Chemistry, Vol.6 (No.11). pp. 1912-1917. ISSN 1477-0520
Full text not available from this repository.
Official URL: http://dx.doi.org/10.1039/B802585A
Abstract
2,3-Diaminobutyric acid (DABA) is an unusual di-amino acid component of mureidomycin A, a member of the peptidylnucleoside antibiotic family produced by Streptomyces flavidovirens SANK 60486. Radiochemical assays using cell-free extract from S. flavidovirens revealed that 14C-L-Thr is converted into radiolabelled DABA by an ammonia-dependent β-replacement activity, and not via oxidation to 3-keto-2-aminobutyric acid. The substrate specificity of partially purified enzyme was assayed using a spectrophotometric assay, and β-replacement activity was inhibited by known inhibitors of PLP-dependent enzymes. These data imply that DABA is biosynthesised from L-Thr by a PLP-dependent β-replacement enzyme, using ammonia as a nucleophile. These results are consistent with literature proposals for the biosynthesis of 2,3-diaminopropanoic acid from the viomycin biosynthetic gene cluster.
| Item Type: | Journal Article |
|---|---|
| Subjects: | Q Science > QD Chemistry Q Science > QP Physiology |
| Divisions: | Faculty of Science > Chemistry |
| Library of Congress Subject Headings (LCSH): | Substitution reactions, Butyric acid, Antibiotics, Biosynthesis |
| Journal or Publication Title: | Organic & Biomolecular Chemistry |
| Publisher: | Royal Society of Chemistry |
| ISSN: | 1477-0520 |
| Date: | 2008 |
| Volume: | Vol.6 |
| Number: | No.11 |
| Page Range: | pp. 1912-1917 |
| Identification Number: | 10.1039/b802585a |
| Status: | Peer Reviewed |
| Publication Status: | Published |
| Funder: | Biotechnology and Biological Sciences Research Council (Great Britain) (BBSRC), Erasmus Mundus (Program) |
| References: | 1 K. I. Kimura and T. D. H. Bugg, Nat. Prod. Rep., 2000, 20, 252. 2 T. D. H. Bugg, A. J. Lloyd and D. I. Roper, Infectious Disorders–Drug Targets, 2006, 6, 85. 3 F. Isono, M. Inukai, S. Takahashi, T. Haneishi, T. Kinoshita; and H. Kuwano, J. Antibiot., 1989, 42, 667. 4 F. Isono, T. Katayama, M. Inukai and T. Haneishi, J. Antibiot., 1989, 42, 674. 5 M. Inukai, F. Isono, S. Takahashi, S. Enokita, Y. Sakaida and T. Haneishi, J. Antibiot., 1989, 42, 662. 6 F. Isono andM. Inukai, Antimicrob. Agents Chemother., 1991, 35, 234. 7 M. Inukai, F. Isono and A. Takatsuki, Antimicrob. Agents Chemother., 1993, 37, 980. 8 J. P. Karwowski,M. Jackson, R. J. Theriault, R. H. Chen, G. J. Barlow andM. L. Maus, J. Antibiot., 1989, 42, 506. 9 R. H. Chen, A. M. Buko, D. N. Whittern and J. B. McAlpine, J. Antibiot., 1989, 42, 512. 10 P. B. Fernandes, R. N. Swanson, D. J. Hardy, C. W. Hanson, L. Coen, R. R. Rasmussen and R. H. Chen, J. Antibiot., 1989, 42, 521. 11 R. M. Fronko, J. C. Lee, J. G. Galazzo, S. Chamberland, F. Malouin andM. D. Lee, J. Antibiot., 2000, 53, 1405. 12 V. J. Lee and S. J. Hecker, Med. Res. Rev., 1999, 19, 521. 13 C. G. Boojamra, R. C. Lemoine, J. C. Lee, R. L´eger, K. A. Stein, N. G. Vernier, A. Magon, O. Lomovskaya, P. K. Martin, S. Chamberland, M. D. Lee, S. J. Hecker and V. J. Lee, J. Am. Chem. Soc., 2001, 123, 870. 14 P. E. Brandish,M.K.Burnham, J.T. Lonsdale,R. Southgate, M. Inukai and T. D. H. Bugg, J. Biol. Chem., 1996, 271, 7609. 15 P. E. Brandish, K. Kimura, M. Inukai, R. Southgate, J. T. Lonsdale and T. D. H. Bugg, Antimicrob. Agents Chemother., 1996, 40, 1640. 16 C. A. Gentle and T. D. H. Bugg, J. Chem. Soc., Perkin Trans. 1, 1999, 1279. 17 C. A. Gentle, S. A. Harrison, M. Inukai and T. D. H. Bugg, J. Chem. Soc., Perkin Trans. 1, 1999, 1287. 18 N. I. Howard and T. D. H. Bugg, Bioorg. Med. Chem., 2003, 11, 3083. 19 W. Aretz, J. Meiwes,G. Seibert,G. Vobis and J.Wink, J. Antibiot., 2000, 53, 807. 20 B. Heinemann, M. A. Kaplan, R. D.Muir and I. R. Hooper, Antibiot. Chemother., 1953, 3, 1239. 21 J. Shoji, S. Kozuki, S. Okamoto, R. Sakazaki and H. Otsuka, J. Antibiot., 1968, 21, 439. 22 W. H. Martin andW. K. Hausmann, J. Am. Chem. Soc., 1960, 82, 2079. 23 A. D. Argoudelis, S.A. Mizsak, J. L. Baczynsky and R. J. Wnuk, J. Antibiot., 1976, 29, 1117. 24 L. A. McDonald, L. R. Barbieri, G. T. Carter, E. Lenoy, J. Lotvin, P. J. Petersen, M. M. Siegel, G. Singh and R. T. Williamson, J. Am. Chem. Soc., 2002, 124, 10260. 25 H. Umezawa, T. Aoyagi, H. Morishima, S. Kunimoto, M. Matsuzaki, M. Hamada and T. Takeuchi, J. Antibiot., 1970, 23, 425. 26 H. Tong and L. Davis, J. Biol. Chem., 1994, 269, 4057. 27 D. McGilvray and J. Morris, Biochem. J., 1969, 112, 657. 28 A. E. Braunstein and E. V. Goryachenkova, Adv. Enzymol., 1994, 56, 1. 29 R. Banerjee, R. Evande, O. Kabil, S. Ojha and S. Taoka, Biochim. Biophys. Acta, 2003, 1647, 30. 30 R. Tripier, F. Chuburu, M. Le Baccon and H. Handel, Tetrahedron, 2003, 59, 4573. 31 M. Y. Khuhauer, A. J. Kandro and F. D. Khand, Anal. Letters, 2006, 39, 2205; L. B.Volodarskii, L.N. Grigoreva and A.Y. Tikhonov, Chem. Heterocycl. Compd., 1983, 19, 1128. 32 R. B. Silverman and G. T. Olson, Bioorg. Med. Chem., 1995, 3, 11. 33 T. S. Soper and J. M. Manning, J. Biol. Chem., 1977, 252, 1571. 34 M. G. Thomas, Y. A. Chan and S. G. Ozanick, Antimicrob. Agents Chemother., 2003, 47, 2823. 35 D. Q. Sun, V. Jones, E. I. Carson, R. E. B. Lee, M. S. Scherman,M. R. McNeil and R. E. Lee, Bioorg. Med. Chem. Lett., 2007, 17, 6899. |
| URI: | http://wrap.warwick.ac.uk/id/eprint/40293 |
Actions (login required)
![]() |
View Item |
Tools
Tools

